Status:

COMPLETED

Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide

Lead Sponsor:

European Society for Blood and Marrow Transplantation

Collaborating Sponsors:

Jazz Pharmaceuticals

Deutsche Krebshilfe e.V., Bonn (Germany)

Conditions:

Hepatic Veno-Occlusive Disease

Eligibility:

All Genders

Up to 18 years

Phase:

PHASE2

PHASE3

Brief Summary

The aim of this trial is to evaluate whether the prophylactic use of Defibrotide (DF) in pediatric patients (age less than 18 years) undergoing stem cell transplantation and who are at high risk of de...

Detailed Description

Comparison/control intervention and duration of the intervention: Patients will be assigned randomly to either the Defibrotide (DF) prophylaxis arm or the control arm. Those allocated to the DF proph...

Eligibility Criteria

Inclusion

  • Age \<18 years
  • myeloablative conditioning and autologous or allogeneic stem cell transplantation with at least one of the following risk factors for VOD:
  • Pre-existing liver disease
  • Second myeloablative HSCT
  • History of treatment with gemtuzumab ozogamicin (MYLOTARGÒ, GO, CMA-676, Wyeth)
  • Allogeneic HSCT for leukemia beyond the second relapse
  • Osteopetrosis (OP)
  • Conditioning with busulfan and melphalan
  • Macrophage activating syndromes (MAS, like hemophagocytic lymphohistiocytosis, Griscelli, Chediak-Higashi
  • Adrenoleukodystrophy (ALD)

Exclusion

  • Pregnant patients
  • Patients who are transplanted but do not fulfill any of the above mentioned criteria

Key Trial Info

Start Date :

December 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2009

Estimated Enrollment :

360 Patients enrolled

Trial Details

Trial ID

NCT00272948

Start Date

December 1 2005

End Date

July 1 2009

Last Update

June 9 2011

Active Locations (30)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (30 locations)

1

University Hospital

Graz, Austria

2

St Anna Kinderspital

Vienna, Austria

3

Inst. Gustave Roussy

Villejuif, France

4

University Hospital

Dresden, Germany

Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide | DecenTrialz